INOPASE - Performance and Safety Study of a Personalised SNM System

NANot yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 1, 2025

Primary Completion Date

February 20, 2026

Study Completion Date

June 28, 2026

Conditions

Overactive Bladder (OAB)

Interventions

DEVICE

Sacral Neuromodulation System

INOPASE Sacral Neuromodulation System (INO-SNM-01) for treatment of overactive bladder.

Trial Locations (2)

St George Private Hospital, Kogarah

St George Urology, Kogarah

All Listed Sponsors

lead

INOPASE Pty Ltd

INDUSTRY

NCT07193407 - INOPASE - Performance and Safety Study of a Personalised SNM System | Biotech Hunter | Biotech Hunter